Mitsuhiro Fujihara

Dr. Mitsuhiro Fujihara


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2003 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
MFMitsuhiro Fujihara
Mitsuhiro Fujihara
MMMasashi Muroi
Masashi Muroi
KTKen-Ichi Tanamoto
Ken-Ichi Tanamoto
TSTsuneo Suzuki
Tsuneo Suzuki
HAHiroshi Azuma
Hiroshi Azuma
HIHisami Ikeda
Hisami Ikeda

22 July 2003 in Transfusion
Verified
Journal Article
Closed access
PDF file
SWShinobu Wakamoto
Shinobu Wakamoto
MFMitsuhiro Fujihara
Mitsuhiro Fujihara
KKKazuhiro Kuzuma
Kazuhiro Kuzuma
SSShinichiro Sato
Shinichiro Sato
TKToshiaki Kato
Toshiaki Kato
HIHisami Ikeda
Hisami Ikeda

20 December 2006 in Transfusion
Verified
Journal Article
Closed access
PDF file
HSHisako Sakagawa
Hisako Sakagawa
TMToru Miyazaki
Toru Miyazaki
MFMitsuhiro Fujihara
Mitsuhiro Fujihara
SSShinichiro Sato
Shinichiro Sato
MYMiki Yamaguchi
Miki Yamaguchi
HIHisami Ikeda
Hisami Ikeda

1 August 2000 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
MFMitsuhiro Fujihara
Mitsuhiro Fujihara
SWShinobu Wakamoto
Shinobu Wakamoto
TITakatoshi Ito
Takatoshi Ito
MMMasashi Muroi
Masashi Muroi
TSTsuneo Suzuki
Tsuneo Suzuki
KIKenji Ikebuchi
Kenji Ikebuchi
Activation of nuclear factor κB (NF-κB) is thought to be required for cytokine production by lipopolysaccharide (LPS)-responsive cells. Here, we investigated the contribution of NF-κB in preventing LPS-induced transcription of the tumor necrosis factor α (TNF-α) gene in a murine macrophage cell line, P388D1, when tolerance was induced in the cells with a short exposure to a higher dose of LPS. Electrophoretic mobility shift assays with the κB elements of the murine TNF-α promoter and enhancer revealed that nuclear mobilization of heterodimers of p65/p50, c-rel/p50 and p65/c-rel, and homodimers of p65 was markedly reduced in LPS-tolerant cells, whereas that of p50 homodimers was only slightly increased. Western blot analysis showed that the phosphorylation of Ser32 on IκBα and its transient degradation did not occur in LPS-tolerant cells. These results thus suggest that desensitization of TNF-α gene expression in this LPS-tolerant state is closely associated with down-regulation of transactivating NF-κB and may involve a defect in the LPS-induced IκBα kinase pathway.

26 October 2010 in Transfusion
Verified
Journal Article
Closed access
PDF file
SWShinobu Wakamoto
Shinobu Wakamoto
MFMitsuhiro Fujihara
Mitsuhiro Fujihara
DTDaisuke Takahashi
Daisuke Takahashi
KNKoichi Niwa
Koichi Niwa
SSShinichiro Sato
Shinichiro Sato
HIHisami Ikeda
Hisami Ikeda

Verified
Journal Article
Open access
PDF file
HAHiroshi Azuma
Hiroshi Azuma
MFMitsuhiro Fujihara
Mitsuhiro Fujihara
HSHiromi Sakai
Hiromi Sakai
Hemoglobin vesicles (HbVs) are oxygen carriers consisting of Hb molecules and liposome in which human hemoglobin (Hb) molecules are encapsulated. Investigations of HbV biocompatibility have shown that HbVs have no significant effect on either the quality or quantity of blood components such as RBC, WBC, platelets, complements, or coagulation factors, reflecting its excellent biocompatibility. However, their effects on the immune system remain to be evaluated. HbVs might affect the function of macrophages because they accumulate in the reticuloendothelial system. Results show that splenic T cell proliferation is suppressed after injection of not only HbV but also empty liposome into rat, and show that macrophages that internalized liposomal particles are responsible for the suppression. However, the effect is transient. Antibody production is entirely unaffected. Further investigation revealed that those macrophages were similar to myeloid-derived suppressor cells (MDSCs) in terms of morphology, cell surface markers, and the immune-suppression mechanism. Considering that MDSCs appear in various pathological conditions, the appearance of MDSC-like cells might reflect the physiological immune system response against the substantial burden of liposomal microparticles. Therefore, despite the possible induction of immunosuppressive cells, HbVs are an acceptable and promising candidate for use as a blood substitute in a clinical setting.